Axios @axios
The FDA said there is "no evidence" that a second round of the Pfizer COVID pill will help patients who suffer a relapse in symptoms. That directly contradicts comments from Pfizer CEO Albert Bourla. https://t.co/IcdBk6hxmQ — PolitiTweet.org